Maureen Ward

Title: Maureen Ward - Innovator in Retroviral Packaging Technology

Introduction

Maureen Ward is a distinguished inventor based in New York, NY (US). She has made significant contributions to the field of retroviral packaging technology. Her innovative work has led to the development of a unique patent that enhances the efficiency of retroviral vectors.

Latest Patents

Maureen Ward holds a patent for an invention titled "RD114-based retroviral packaging cell line and related compositions and methods." This invention provides a retroviral packaging cell comprising a suitable mammalian cell that contains a first recombinant nucleic acid with MMLV gag and pol genes, along with a selectable marker. Additionally, it includes a second recombinant nucleic acid comprising the RD114 envelope gene and another selectable marker. The MMLV gag and pol genes, as well as the RD114 envelope gene, are stably expressed in the cell. This invention further encompasses related production methods, virions, and kits. She has 1 patent to her name.

Career Highlights

Maureen Ward is affiliated with Columbia University, where she continues her research and development in the field of retroviral technology. Her work has been instrumental in advancing the understanding and application of retroviral vectors in various biomedical fields.

Collaborations

One of her notable collaborators is Arthur Bank, with whom she has worked closely on various projects related to her patent.

Conclusion

Maureen Ward's innovative contributions to retroviral packaging technology exemplify her dedication to advancing scientific research. Her patent reflects her expertise and commitment to improving methodologies in the field.